DE68904364D1 - (aza)naphtalensultam-derivate, verfahren zu deren herstellung und arzneimittel, die sie enthalten. - Google Patents

(aza)naphtalensultam-derivate, verfahren zu deren herstellung und arzneimittel, die sie enthalten.

Info

Publication number
DE68904364D1
DE68904364D1 DE8989401948T DE68904364T DE68904364D1 DE 68904364 D1 DE68904364 D1 DE 68904364D1 DE 8989401948 T DE8989401948 T DE 8989401948T DE 68904364 T DE68904364 T DE 68904364T DE 68904364 D1 DE68904364 D1 DE 68904364D1
Authority
DE
Germany
Prior art keywords
naphtalensultam
aza
derivatives
production
products containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8989401948T
Other languages
English (en)
Other versions
DE68904364T2 (de
Inventor
Marie-Therese Comte
Claude Gueremy
Jean-Luc Malleron
Serge Mignani
Jean-Francois Peyronel
Alain Truchon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc Sante SA
Original Assignee
Rhone Poulenc Sante SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8809218A external-priority patent/FR2633928B1/fr
Priority claimed from FR8902167A external-priority patent/FR2643265B1/fr
Application filed by Rhone Poulenc Sante SA filed Critical Rhone Poulenc Sante SA
Publication of DE68904364D1 publication Critical patent/DE68904364D1/de
Application granted granted Critical
Publication of DE68904364T2 publication Critical patent/DE68904364T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Cephalosporin Compounds (AREA)
DE8989401948T 1988-07-07 1989-07-06 (aza)naphtalensultam-derivate, verfahren zu deren herstellung und arzneimittel, die sie enthalten. Expired - Fee Related DE68904364T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8809218A FR2633928B1 (fr) 1988-07-07 1988-07-07 Derives de (aza)naphtalenesultame, leurs procedes de preparation et les medicaments les contenant
FR8902167A FR2643265B1 (fr) 1989-02-20 1989-02-20 Derives de (aza)naphto(1,8-cd)isothiazole dioxyde-1,1 leurs procedes de preparation et les medicaments les contenant

Publications (2)

Publication Number Publication Date
DE68904364D1 true DE68904364D1 (de) 1993-02-25
DE68904364T2 DE68904364T2 (de) 1993-07-15

Family

ID=26226778

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8989401948T Expired - Fee Related DE68904364T2 (de) 1988-07-07 1989-07-06 (aza)naphtalensultam-derivate, verfahren zu deren herstellung und arzneimittel, die sie enthalten.

Country Status (18)

Country Link
US (2) US5021420A (de)
EP (1) EP0350403B1 (de)
JP (1) JP2763791B2 (de)
KR (1) KR0138908B1 (de)
AU (1) AU620114B2 (de)
CA (1) CA1326483C (de)
DE (1) DE68904364T2 (de)
DK (1) DK335489A (de)
ES (1) ES2054057T3 (de)
FI (1) FI93114C (de)
GR (1) GR3006775T3 (de)
HU (1) HU210833B (de)
IE (1) IE62364B1 (de)
IL (1) IL90858A (de)
NO (1) NO179007C (de)
NZ (1) NZ229856A (de)
PT (1) PT91098B (de)
TW (1) TW197440B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2656306A1 (fr) * 1989-12-26 1991-06-28 Rhone Poulenc Sante Derives heterocycliques, leur preparation et les medicaments les contenant.
EP0429341A3 (en) * 1989-11-20 1991-11-13 Rhone-Poulenc Sante Heterocyclic derivatives, their preparation and pharmaceuticals containing them
FR2663635A2 (fr) * 1989-12-26 1991-12-27 Rhone Poulenc Sante Derives heterocycliques, leur preparation et les medicaments les contenant.
FR2662696A2 (fr) * 1989-12-13 1991-12-06 Rhone Poulenc Sante Antagonistes de la serotonine, leur preparation et medicaments les contenant.
FR2661177A1 (fr) * 1990-04-23 1991-10-25 Rhone Poulenc Sante Derives du naphtosultame antagonistes de la serotonine, leur preparation et les medicaments les contenant.
FR2675801A1 (fr) * 1991-04-24 1992-10-30 Rhone Poulenc Rorer Sa Piperidines, leur preparation et les medicaments les contenant.
FR2675800A1 (fr) * 1991-04-26 1992-10-30 Rhone Poulenc Rorer Sa Derives heterocycliques antiserotonines leur preparation et les medicaments les contenant.
US5202321A (en) * 1991-06-13 1993-04-13 Merck Frosst Canada, Inc. Thiopyrano[2,3,4-c,d]indoles as inhibitors of leukotriene biosynthesis
FR2687575A1 (fr) * 1992-02-24 1993-08-27 Rhone Poulenc Rorer Sa Application du [[(fluoro-4 phenyl)-4 piperazinyl-1]-3 propyl]-2 2h naphto [1,8-cd] isothiazole dioxyde-1,1 pour obtenir un medicament anorexigene.
US6001827A (en) * 1993-12-24 1999-12-14 Suntory Limited Benzothiazine derivative
CN1058492C (zh) * 1993-12-24 2000-11-15 三得利株式会社 苯并噻嗪衍生物
US5874429A (en) * 1993-12-24 1999-02-23 Suntory Limited Benzothiazine derivative
GB9416571D0 (en) * 1994-08-16 1994-10-12 Battelle Memorial Institute Novel alkylamino derivatives as sigma 2 selective ligands
SE9902765D0 (sv) 1999-07-21 1999-07-21 Astra Pharma Prod Novel compounds
US6521630B1 (en) 1999-08-31 2003-02-18 Pfizer Inc. Tetrahydroquinazoline-2,4-diones and therapeutic uses thereof
US6844338B2 (en) 2000-05-18 2005-01-18 Eli Lilly And Company Piperidyindoles as serotonin receptor ligands
GB2362381A (en) * 2000-05-18 2001-11-21 Lilly Co Eli Pharmaceutically active indolyl-piperidines
JP5066443B2 (ja) * 2005-02-25 2012-11-07 興和株式会社 ４−フルオロイソキノリン−５−スルホニルハライド又はその塩の製造方法
CN101622243B (zh) 2007-02-28 2013-12-04 旭化成制药株式会社 磺酰胺衍生物
IN2015MN00002A (de) 2012-07-09 2015-10-16 Lupin Ltd
CN108299411B (zh) * 2017-01-13 2021-02-05 中国人民解放军军事医学科学院毒物药物研究所 4,4-二苯基哌啶类化合物或其可药用盐、药物组合物及用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE755589A (fr) * 1969-09-03 1971-03-02 Janssen Pharmaceutica Nv Benzimidazoolcarbamaten
DE2139084C3 (de) * 1971-08-04 1979-03-01 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Verfahren zur Herstellung von 4,4-Diphenyl-piperidinen
US4110449A (en) * 1977-05-23 1978-08-29 E. R. Squibb & Sons, Inc. 2-substituted benzisothiazol-3-ones
US4485107A (en) * 1982-11-01 1984-11-27 Janssen Pharmaceutica N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones
JPS59229556A (ja) * 1983-06-13 1984-12-24 Konishiroku Photo Ind Co Ltd 熱現像カラ−感光要素
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
GB8510840D0 (en) * 1985-04-29 1985-06-05 Allied Corp Electrical connectors

Also Published As

Publication number Publication date
HUT56098A (en) 1991-07-29
JP2763791B2 (ja) 1998-06-11
PT91098A (pt) 1990-02-08
AU3790689A (en) 1990-01-11
IE62364B1 (en) 1995-01-25
FI893297A (fi) 1990-01-08
FI893297A0 (fi) 1989-07-06
NO179007B (no) 1996-04-09
CA1326483C (fr) 1994-01-25
NO179007C (no) 1996-07-17
JPH0267274A (ja) 1990-03-07
FI93114C (fi) 1995-02-27
IL90858A0 (en) 1990-02-09
ES2054057T3 (es) 1994-08-01
GR3006775T3 (de) 1993-06-30
AU620114B2 (en) 1992-02-13
IL90858A (en) 1994-08-26
FI93114B (fi) 1994-11-15
KR900001707A (ko) 1990-02-27
DK335489A (da) 1990-01-08
HU210833B (en) 1995-08-28
US5021420A (en) 1991-06-04
IE892189L (en) 1990-01-07
DK335489D0 (da) 1989-07-06
KR0138908B1 (ko) 1998-05-15
US5036075A (en) 1991-07-30
TW197440B (de) 1993-01-01
NZ229856A (en) 1990-08-28
PT91098B (pt) 1994-12-30
EP0350403A1 (de) 1990-01-10
DE68904364T2 (de) 1993-07-15
NO892808L (no) 1990-01-08
NO892808D0 (no) 1989-07-06
EP0350403B1 (de) 1993-01-13

Similar Documents

Publication Publication Date Title
DE68904364T2 (de) (aza)naphtalensultam-derivate, verfahren zu deren herstellung und arzneimittel, die sie enthalten.
DE68904104T2 (de) Phenol-substituierte gem-diphosphonat-derivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
DE3671627D1 (de) Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung.
ATE150033T1 (de) N,o-sulfatierte heparosane; verfahren zu deren herstellung und diese enthaltende arzneimittel
ATA315488A (de) Neue adenosinderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische praeparate
DE3575724D1 (de) Quinolizinon-verbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DE68908374D1 (de) Propenonoximether, verfahren zu dessen herstellung sowie diese enthaltende arzneinmittel.
DE3770982D1 (de) Diphosphonsaeure-verbindungen, verfahren zu deren herstellung und sie enthaltende arzneimittel.
DE68905585T2 (de) 2-imino-benzothiazolin-derivate, verfahren zu deren herstellung und arzneimittel, die sie enthalten.
DE3777122D1 (de) Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3579000D1 (de) Imidazolylalkylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
DE68901039D1 (de) Indolylpiperidin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische verbindungen.
AT397797B (de) Capsaicin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3577199D1 (de) Semicarbazidderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DE68903484T2 (de) 2-imino-6-polyfluoralkoxy-benzothiazol-derivate, verfahren zu deren herstellung und arzneimittel, die sie enthalten.
DE3576686D1 (de) Chinolinone, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen praeparate.
DE3483515D1 (de) Zuckerdragiertes arzneimittel und verfahren zu dessen herstellung.
DE3868309D1 (de) Imidazol-derivate, verfahren zu deren herstellung, diese enthaltende pharmazeutische zusammenstellungen und deren anwendung als arzneimittel.
DE68903425T2 (de) Verbindungen mit zentraler analgetischer verwendung, verfahren zu ihrer herstellung und arzneimittel die sie enthalten.
DE3767894D1 (de) 1,2-dithiol-3-thion-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung.
DE3883164D1 (de) Rhodanin-derivate, verfahren zu ihrer herstellung, ihre anwendung und pharmazeutische zusammensetzungen, die sie enthalten.
DE3785987T2 (de) Imidazol-derivate und deren salze, verfahren zu deren herstellung, deren anwendung als arzneimittel und deren zusammensetzungen.
DE3676360D1 (de) Nitroderivate von vinblastintyp-bis-indolen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ATE9795T1 (de) Benzoyl-phenyl-piperidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE87310T1 (de) 2-imino-benzothiazolin-derivate, verfahren zu deren herstellung und arzneimittel, die sie enthalten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee